| Literature DB >> 23029013 |
Yi-Fan Zhang1, Yoshikazu Kitano, Yasuyuki Nogata, Yu Zhang, Pei-Yuan Qian.
Abstract
Isocyanide is a potential antifouling compound in marine environments. In this study, we investigated its mode of action in three aquatic organisms. Two of them, the bryozoan Bugula neritina and the barnacle Balanus amphitrite, are major marine fouling invertebrates, and the other organism is the non-target species zebrafish Danio rerio. In the swimming larvae of B. neritina, isocyanide did not affect the total attachment rate (≤50 µg ml(-1)), but it did change the attachment site by increasing the percentage of attachment on the bottom of the container rather than on the wall or air-water inter-surface. Isocyanide binds several proteins in B. neritina as identified via SDS-PAGE-LC-MS/MS: 1) a 30 kD protein band containing two proteins similar to voltage dependent anion channels (VDAC), which control the direct coupling of the mitochondrial matrix to the energy maintenance of the cytosol and the release of apoptogenic factors from mitochondria of mammalian cells; and 2) an unknown 39 kD protein. In B. amphitrite cyprids, the isocyanide binding protein were 1) a protein similar to NADH-ubiquinone oxidoreductase, which is the "entry enzyme" of oxidative phosphorylation in mitochondria; and 2) cytochrome P450. In Danio rerio embryos, isocyanide caused "wavy" notochords, hydrocephalus, pericardial edema, poor blood circulation, and defects in pigmentation and hematopoiesis, which phenocopied copper deficiency. This is the first report on isocyanide binding proteins in fouling organisms, as well as the first description of its phenotype and potential toxicology in zebrafish.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23029013 PMCID: PMC3445549 DOI: 10.1371/journal.pone.0045442
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Chemical structures and affinity pull down assay results of isocyanide binding proteins.
a–c) Chemical structure of a) isocyanide 1 [11-Isocyano-11-methyldodec-1-ene], b) isocyanide 2 [10-isocyano-10-methylundecan-1-amine], c) isocyanide 2 conjugated with the matrix (isocyanide-matrix). d–e) The coomassie blue G250 stained SDS-PAGE gel of SDS-sample-buffer-eluted proteins that were pulled down by the isocyanide-matrix. The lanes (Block: iso) contain proteins that were pulled down by the isocyanide-matrix in the presence of free isocyanide 2 in the binding solution, thus serving as the competition control for the (Block: -). d) Pulled down from the cell lysate of Bugula neritina swimming larvae. The identity of the protein bands was determined by UPLC-MS/MS (see also Table S1). e) Pulled down from the cell lysate of Balanus amphitrite cyprid. The 50 kD protein band (arrow) contains NADH-ubiquinone oxidoreductase and cytochrome P450 as identified by UPLC-MS/MS. The same cytochrome P450 also showed up in a lower non-specific band (43KD) in another batch of experiment as identified by LC-MS/MS (see also Table S2 and Figure S2).
Figure 2The effect of isocyanide 1 on the attachment and survival of Bugula neritina (observed at 48 h).
Error bars represent standard errors. n ≥40 under each test condition.
Figure 3The effect of isocyanide 1 on Danio rerio (zebrafish) embryos.
Zebrafish embryos were treated with isocyanide 1 at different concentrations from the early developmental stages (<2 hpf). a–f) Observed at 28 hpf. g–l) observed at 48 hpf; m–r) observed at 74 hpf; s–x) observed at 96 hpf; a,g,m,s) the control; b,h,n,t) 0.5 µg ml−1 isocyanide 1 treated; c,i,o,u) 1 µg ml−1 isocyanide 1 treated; d,j,p,v) 1.5 µg ml−1 isocyanide 1 treated; e,k,q,w) 2 µg ml−1 isocyanide 1 treated; f,l,r,x) 2.5 µg ml−1 isocyanide 1 treated. Note the “wavy” notochord (black arrowheads) and the hydrocephalus (black arrows) at concentrations ≥1 µg ml−1. Also note the pigmentation defect in the eyes (red arrows) and bodies of treated embryos. The red arrowheads point to pericardial edema, which developed under high concentrations. The rectangles in panels a and c indicate the area shown at higher magnification in panels y and z, respectively. y,z) High magnification of the embryo head at 28 hpf in the y) control and z) 1 µg ml−1 isocyanide 1, revealing abnormal development in the isocyanide 1-treated embryo (compare the structure indicated with blue arrowheads). β,θ) High magnification of the embryo notochord at 28 hpf in the β) control and θ) 1 µg ml−1 isocyanide 1, revealing a wavy notochord in the isocyanide 1-treated embryo. δ,ε) Top view of embryo at 72 hpf in the δ) control and ε) 1 µg ml−1 isocyanide 1, revealing the lateral undulation of the notochords in the isocyanide 1-treated embryo.
Dose- and time-dependent effects of isocyanide 1 on zebrafish Danio rerio embryos.
| Concentration of isocyanide 1 | Number of zebrafish embryos | |||||||||||
| Eye pigmentation | Notochord | Head | Pericardial | Hematopoiesis | ||||||||
| µg ml−1 | Total | Normal | Light | Straight | Wavy | Normal | Hydrocephalus | Normal | Edema | Normal | Deficient | Observation time |
| 0 | 9 | 9 | 0 | 9 | 0 | 9 | 0 | 9 | 0 | 9 | 0 | 72 hpf |
| 0.5 | 8 | 3 | 5 | 8 | 0 | 8 | 0 | 5 | 3 | 5 | 3 | 72 hpf |
| 1 | 11 | 0 | 11 | 0 | 11 | 0 | 11 | 8 | 3 | 1 | 10 | 72 hpf |
| 1.5 | 10 | 0 | 10 | 0 | 10 | 0 | 10 | 9 | 1 | 7 | 3 | 72 hpf |
| 2 | 10 | 0 | 10 | 0 | 10 | 0 | 10 | 5 | 5 | 1 | 9 | 72 hpf |
| 2.5 | 11 | 0 | 11 | 0 | 11 | 0 | 11 | 2 | 9 | 0 | 11 | 72 hpf |
| 0 | 9 | 9 | 0 | 9 | 0 | 9 | 0 | 9 | 0 | 9 | 0 | 96 hpf |
| 0.5 | 8 | 6 | 2 | 8 | 0 | 8 | 0 | 7 | 1 | 8 | 0 | 96 hpf |
| 1 | 11 | 5 | 6 | 0 | 11 | 0 | 11 | 7 | 4 | 8 | 3 | 96 hpf |
| 1.5 | 10 | 3 | 7 | 0 | 10 | 0 | 10 | 8 | 2 | 10 | 0 | 96 hpf |
| 2 | 10 | 0 | 10 | 0 | 10 | 0 | 10 | 4 | 6 | 8 | 2 | 96 hpf |
| 2.5 | 11 | 0 | 11 | 0 | 11 | 0 | 11 | 2 | 9 | 0 | 11 | 96 hpf |
The treatment started within 2 hours post fertilization (hpf).
A comparison of biological effects between isocyanide 1 and butenolide.
| Species | Butenolide | Isocyanide 1 | |
| Inhibited species | Field test | invertebrates/diatom | Invertebrates |
| Effective concentrations (µg ml−1) |
| 0.33 (5d IC50) | NA |
|
| 3.02 (LC50) | NA | |
|
| 2.56 (LC50) | NA | |
|
| 2.34 (EC50) | NA | |
|
| 1.32 (LC50) | NA | |
|
| 0.89 (EC50) | <0.5(EC50) | |
|
| 0.518 (EC50) | 0.046 (EC50) | |
|
| 0.199 (EC50) | 0.1 (LOEC) | |
|
| 0.0168 (EC50) | NA | |
| PNEC (µg ml−1) | 0.000168 | NA | |
| PEC | NA | NA | |
| Species selectivity ratio | 0.635 | NA | |
| Toxicology in non-target organism |
| apoptosis | copper deficiency |
| Binding partners in target organisms | General impression | affect primary metabolism for energygeneration | affect mitochondrial functions |
|
| ACAT1 (affect ketonebody synthesis) | NADH-ubiquinone oxidoreductase (affect electron transport chain)and CYP | |
|
| ACADVL (affect fattyacid β-oxidation),actin and GSTs | VDAC (affect mitochondrialenergy transport/apoptosis) | |
|
| SCSβ (affect citricacid cycle) | NA | |
| metabolites/degradation products | NA | NA |
Predicted no effect concentration (PNEC) is calculated according to the guidelines for the testing of chemicals from the Organization for Economic Co-operation and Development (OECD) (http://www.oecd.org/dataoecd/6/14/2483645.pdf).
Predicted environmental concentration (PEC).
Species-selectivity ratio (based on acute toxicity test) = lowest L(E)C50 in non-target organisms/highest EC50 in target organisms determined preferably by settlement assay [13].
Based on phenotype matching in zebrafish Danio rerio.
Based on affinity pull down assay.
NA: data not available.
The lowest observed effective concentration (LOEC) to induce attachment site change in Bugula neritina. It should be noted that although the isocyanide 1 did not effectively inhibit the fouling of Bugula neritina in laboratory, it changed the settling site of this organism (Figure 2) and also effectively inhibited biofouling of Bugula neritina in field tests [6].